FDA Oncology Center of Excellence Review Processes and Tools

Clin Pharmacol Ther. 2020 Sep;108(3):428-429. doi: 10.1002/cpt.1945. Epub 2020 Jul 12.

Authors

Jennifer J Gao¹, Paul G Kluetz¹, Richard Pazdur¹

Affiliation

¹ Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA.

PMID: 32654129
DOI: 10.1002/cpt.1945

No abstract available

MeSH terms

Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Drug Approval*
Humans
Medical Oncology*
Patient Safety
Risk Assessment
Treatment Outcome
United States
United States Food and Drug Administration*

Substances

Antineoplastic Agents